Potent and Selective PTDSS1 Inhibitors Induce Collateral Lethality in Cancers with PTDSS2 Deletion.
Yoshihama Y, Namiki H, Kato T, Shimazaki N, Takaishi S, Kadoshima-Yamaoka K, Yukinaga H, Maeda N, Shibutani T, Fujimoto K, Hirasawa M, Goto H, Wada N, Tsutsumi S, Hirota Y, Ishikawa T, Yamamoto S.
Yoshihama Y, et al. Among authors: tsutsumi s.
Cancer Res. 2022 Nov 2;82(21):4031-4043. doi: 10.1158/0008-5472.CAN-22-1006.
Cancer Res. 2022.
PMID: 36054550